Gefitinib-Induced Interstitial Lung Disease in Korean Lung Cancer Patients

PURPOSE: Interstitial lung disease (ILD) is a serious adverse effect of gefitinib. We examined the incidence and clinical characteristics of drug-induced ILD in Korean non-small cell lung carcinoma patients treated with gefitinib. MATERIALS AND METHODS: A retrospective cohort study was performed in...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cancer Res Treat
Asıl Yazarlar: Beom, Seung-Hoon, Kim, Dong-Wan, Sim, Sung Hoon, Keam, Bhumsuk, Park, Jin Hyun, Lee, Jeong-Ok, Kim, Tae Min, Lee, Se-Hoon, Heo, Dae Seog
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Korean Cancer Association 2016
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4720097/
https://ncbi.nlm.nih.gov/pubmed/25761482
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2014.201
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller